A comparison of cost-effectiveness of peginterferon alfa-2a (40KD) (Pegasys) plus ribavirin (copegus) vs interferon alfa-2b plus ribavirin as first treatment of chronic hepatitus C (CHC)
- 30 April 2003
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 38, 174-175
- https://doi.org/10.1016/s0168-8278(03)80867-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: